Sundeep Agrawal
CIK: 0001840599
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
Conversion(C)Indirect578.5K shares- - Aug 6, 2026BLSM
BlossomHill Therapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
23.9K shares- - Apr 2, 2026PAVM
PAVmed Inc.
Award(A)Direct13.9K shares- - Sep 30, 2025PAVM
PAVmed Inc.
Award(A)Direct150K shares- - Oct 21, 2024PAVM
PAVmed Inc.
Award(A)DirectEmployee stock option (right to buy)
50K shares- - Sep 19, 2024PAVM
PAVmed Inc.
Award(A)DirectEmployee stock option (right to buy)
205K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion(C) | 578,524 | - | $0 | Indirect |
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 23,904 | - | - | Direct |
| Apr 2, 2026 | PAVM PAVmed Inc. | Award(A) | 13,930 | - | $0 | Direct |
| Sep 30, 2025 | PAVM PAVmed Inc. | Award(A) | 150,000 | - | - | Direct |
| Oct 21, 2024 | PAVM PAVmed Inc. | Award(A) Employee stock option (right to buy) | 50,000 | - | - | Direct |
| Sep 19, 2024 | PAVM PAVmed Inc. | Award(A) Employee stock option (right to buy) | 205,000 | - | - | Direct |
1-6 of 6 transactions
About Agrawal Sundeep
Agrawal Sundeep (SEC CIK 0001840599) files insider reports with the SEC as Director of BlossomHill Therapeutics, Inc. (BLSM) and Director of PAVmed Inc. (PAVM).
Signal8 holds 7 ownership filings by Agrawal Sundeep (2 Form 3, 5 Form 4), filed between Sep 20, 2024 and Aug 10, 2026. Those filings report 6 transactions, from Sep 19, 2024 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Agrawal Sundeep's filings is in SAN DIEGO, CA.
Recent filings by Agrawal Sundeep
- Aug 10, 2026: Conversion of BLSM shares (Form 4, code C).
- Aug 6, 2026: Grant or award of BLSM derivative securities (Form 4, code A).
- Apr 2, 2026: Grant or award of PAVM shares (Form 4, code A).
- Sep 30, 2025: Grant or award of PAVM shares (Form 4, code A).
- Oct 21, 2024: Grant or award of PAVM derivative securities (Form 4, code A).
Other insiders filing for BlossomHill Therapeutics, Inc. (BLSM)
- GORDON CARL L, Director
- ORBIMED ADVISORS LLC, Director
- Schmid John P., Director
- Chen Bihua, Director
- Keyes Jason A, Chief Financial Officer
- Liptak Vincent Paul, General Counsel